Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Adverum Biotechnologies, Inc. (ADVM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
1.6100+0.1000 (+6.62%)
At close: 04:00PM EDT
1.5750 -0.04 (-2.17%)
After hours: 07:22PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
7,500
0
250
1,612
Operating Expense
155,612
153,622
117,950
68,795
74,693
Operating Income
-155,612
-146,122
-117,950
-68,545
-73,081
Other Income Expense
619
582
1,557
4,059
-796
Pretax Income
-154,993
-145,540
-116,393
-64,486
-73,877
Tax Provision
19
0
1,114
0
-1,250
Net Income Common Stockholders
-155,012
-145,540
-117,507
-64,486
-72,627
Diluted NI Available to Com Stockholders
-155,012
-145,540
-117,507
-64,486
-72,627
Basic EPS
-
-1.48
-1.38
-1.01
-1.18
Diluted EPS
-
-1.48
-1.38
-1.01
-1.18
Basic Average Shares
-
98,039
85,146
64,102
61,375
Diluted Average Shares
-
98,039
85,146
64,102
61,375
Total Operating Income as Reported
-155,612
-146,122
-117,950
-68,545
-78,081
Total Expenses
155,612
153,622
117,950
68,795
74,693
Net Income from Continuing & Discontinued Operation
-155,012
-145,540
-117,507
-64,486
-72,627
Normalized Income
-155,012
-145,540
-117,507
-64,486
-67,712
EBIT
-155,612
-146,122
-117,950
-68,545
-73,081
EBITDA
-150,708
-
-
-
-
Reconciled Depreciation
4,904
4,645
4,158
1,573
1,750
Net Income from Continuing Operation Net Minority Interest
-155,012
-145,540
-117,507
-64,486
-72,627
Total Unusual Items Excluding Goodwill
-
-
0
0
-5,000
Total Unusual Items
-
-
0
0
-5,000
Normalized EBITDA
-150,708
-141,477
-113,792
-66,972
-66,331
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-84.6001
Advertisement
Advertisement